Breast cancer risk assessment and prevention: a framework for shared decision-making consultations

The Breast Journal
Elissa M OzanneLaura J Esserman

Abstract

Options for breast cancer prevention, used in combination with screening and surveillance, include lifestyle modifications, chemoprevention with tamoxifen, and prophylactic surgery. Preventive health decisions are often preference driven: patients typically must choose whether to initiate effective treatments that hold the possibility of side effects that can negatively impact quality of life. This situation demands that patients be well informed and have a full understanding of the risks associated with each option. Investigators have developed a comprehensive decision-making framework designed to support breast cancer prevention consultations within a shared decision-making setting. The framework integrates predictive information from current risk models within the context of a woman's general health to appropriately frame breast cancer risk management consultations and outlines the application of available treatments and emerging biomarker information to individual patient decisions. Using an evidence-based approach, specialized risk-benefit projections can be provided in the clinical setting. A more comprehensive individualized risk profile allows for tailored medical management plans and can better prepare patients to make...Continue Reading

References

Nov 1, 1995·Journal of the National Cancer Institute·C ByrneR Haile
Apr 10, 1995·American Journal of Medical Genetics·M J SellerG S Tint
Mar 16, 1994·Journal of the National Cancer Institute·D V SpicerM C Pike
Nov 1, 1993·Breast Cancer Research and Treatment·E B ClausW D Thompson
Jan 1, 1993·Epidemiologic Reviews·N L Petrakis
Jan 17, 1996·Journal of the National Cancer Institute·S TretliP Vaittinen
Jan 17, 1996·Journal of the National Cancer Institute·G UrsinR W Reitherman
May 15, 1997·The New England Journal of Medicine·J P StruewingM A Tucker
May 15, 1997·The New England Journal of Medicine·F J CouchB L Weber
Oct 23, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I PerssonL Holmberg
Jan 14, 1999·The New England Journal of Medicine·K A PhillipsJ A Knight
May 13, 1999·Family Practice·G H de BockJ Kievit
Jul 29, 1999·Medical Decision Making : an International Journal of the Society for Medical Decision Making·P F StalmeierW A Van Daal
Aug 19, 1999·Journal of the National Cancer Institute·N F BoydD L Tritchler
Aug 27, 1999·JAMA : the Journal of the American Medical Association·A Edwards, G Elwyn
Sep 2, 1999·Journal of the National Cancer Institute·T R RebbeckB L Weber
Nov 5, 1999·Journal of the National Cancer Institute·M H GailV Vogel
Dec 28, 1999·JAMA : the Journal of the American Medical Association·C H BraddockW Levinson
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B MeiserK Tucker
Mar 17, 2001·JAMA : the Journal of the American Medical Association·R YancikJ W Yates
Mar 10, 2001·Journal of the National Cancer Institute·B RockhillG A Colditz
Jul 14, 2001·Health Communication·I M LipkusB K Rimer
Jul 21, 2001·The New England Journal of Medicine·H Meijers-HeijboerJ G Klijn
Aug 18, 2001·Annals of Surgical Oncology·E R PortP I Borgen
Nov 8, 2001·Journal of the National Cancer Institute·W C DooleyE B King
Dec 6, 2001·Journal of the National Cancer Institute·M R WrenschM Rhys
Jan 31, 2002·Annual Review of Medicine·Rowan T Chlebowski
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Jun 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Donald A BerryGiovanni Parmigiani
Jul 3, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Oct 3, 2002·Journal of the National Cancer Institute·Victor G VogelWalter M Cronin
Oct 17, 2002·Journal of the National Cancer Institute·Kelly A Metcalfe, Steven A Narod
Dec 24, 2002·Plastic and Reconstructive Surgery·Zdenko StanecPaul Skoll
Jan 16, 2003·The Medical Journal of Australia·Phyllis N ButowKatherine M Tucker
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan M DomchekBarbara L Weber
Apr 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN American Society of Clinical Oncology
Jun 24, 2003·Cancer Chemotherapy and Pharmacology·Anthony HowellD Gareth Evans
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators

❮ Previous
Next ❯

Citations

Feb 24, 2007·Journal of Genetic Counseling·Claire E WakefieldKathy Tucker
May 18, 2007·Reviews in Endocrine & Metabolic Disorders·Angela R Bradbury, Olufunmilayo I Olopade
Apr 24, 2009·Journal of General Internal Medicine·Saul N WeingartLawrence N Shulman
Nov 21, 2012·Journal of Health Care for the Poor and Underserved·Emily E Anderson, Kent Hoskins
Jan 16, 2014·BMC Medical Informatics and Decision Making·Elissa M OzanneLaura J Esserman
Nov 27, 2007·Cancer Detection and Prevention·Susan A SabatinoRisa B Burns
Feb 27, 2007·The Breast Journal·Elissa M OzanneLaura Esserman
Jul 7, 2011·Journal of Nursing and Healthcare of Chronic Illness·Christine HolmbergWorta McCaskill-Stevens
Mar 5, 2015·Journal of Genetic Counseling·Louise HeinigerUNKNOWN kConFab Psychosocial Group on behalf of the kConFab Investigators
Oct 27, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Bachok Norsa'adahAishah Knight
Oct 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Tam Truong DonnellyFloor Christie-de Jong
Sep 13, 2016·Current Breast Cancer Reports·Susan HumRuth Heisey
Feb 22, 2017·Journal of Clinical Imaging Science·Posy J SeifertAndrea L Arieno
Apr 7, 2007·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Gad Rennert
Nov 30, 2012·Clinical Chemistry·Laura EssermanLaura van't Veer
Sep 26, 2007·Expert Review of Molecular Diagnostics·Laura J EssermanElissa M Ozanne
May 18, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Ayla Acikgoz, Gul Ergor
Jan 1, 2012·American Society of Clinical Oncology Educational Book·Abenaa M BrewsterWorta McCaskill-Stevens
May 17, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Susan E PoriesMarsha A Moses
Apr 22, 2021·Molecular and Cellular Endocrinology·Nusrat JahanRakhshanda Layeequr Rahman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.